GH Research PLC (GHRS)
11.98
+0.33
(+2.83%)
USD |
NASDAQ |
Jun 02, 16:00
11.85
-0.13
(-1.09%)
After-Hours: 20:00
GH Research Net Income (TTM): -27.63M for March 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -27.63M |
| December 31, 2022 | -22.46M |
| September 30, 2022 | -9.961M |
| June 30, 2022 | -11.36M |
| March 31, 2022 | -13.82M |
| Date | Value |
|---|---|
| December 31, 2021 | -9.202M |
| September 30, 2021 | -5.436M |
| June 30, 2021 | -3.659M |
| March 31, 2021 | -1.576M |
| December 31, 2020 | -0.446M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-27.63M
Minimum
Mar 2023
-0.446M
Maximum
Dec 2020
-10.55M
Average
-9.582M
Median
Net Income (TTM) Benchmarks
| Jazz Pharmaceuticals PLC | -156.29M |
| Prothena Corp PLC | -127.52M |
| Nabriva Therapeutics PLC | -54.07M |
| Iterum Therapeutics PLC | -50.82M |
| Mallinckrodt PLC | -1.041B |